TY - JOUR
KW - Buprenorphine -- Therapeutic Use
KW - Telemedicine
KW - COVID-19 -- Drug Therapy
KW - substance use disorders
KW - Analgesics, Opioid
KW - Human
KW - Videoconferencing
KW - homelessness
KW - Adult
KW - Male
KW - Harm Reduction
KW - Substance Use Rehabilitation Programs
AU - Miriam Harris
AU - Samantha Johnson
AU - Sarah Mackin
AU - Richard Saitz
AU - Alexander Y. Walley
AU - Jessica L. Taylor
A1 - 
AD - Grayken Center for Addiction, Boston Medical Center, Boston, MA; Department of Medicine, Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston MA; Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA
BT - Journal of Addiction Medicine
C5 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CP - 4
CY - Baltimore, Maryland
DO - https://doi.org/10.1097%2FADM.0000000000000682
IS - 4
JF - Journal of Addiction Medicine
LA - English
M1 - Journal Article
PB - Lippincott Williams & Wilkins
PP - Baltimore, Maryland
PY - 2020
SN - 1932-0620
SP - e136
EP - e138
EP - 
T1 - Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report
T2 - Journal of Addiction Medicine
TI - Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report
U1 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U3 - https://doi.org/10.1097%2FADM.0000000000000682
VL - 14
VO - 1932-0620
Y1 - 2020
Y2 - Jul
ER -